Le Lézard
Classified in: Health
Subject: SVY

Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 5, 2017 /PRNewswire/ -- Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2017

Summary

Download the full report: https://www.reportbuyer.com/product/5134541

GlobalData's Medical Devices sector report, "Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Hip Reconstruction Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Hip Reconstruction Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hip Reconstruction Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hip Reconstruction Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/5134541

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 01:30
CTI BioPharma Corp. today announced that it expects to receive a $10 million milestone payment in February, 2018 from Teva Pharmaceutical Industries Ltd.  related to the achievement of a milestone for U.S. Food and Drug Administration approval of...

17 jan 2018
Fluke Biomedical, RaySafe and LANDAUER will be demonstrating several new products at the Arab Health Exhibition and Congress held 29 January through 1 February at the Dubai International Convention and Exhibition Centre, Dubai, United Arab Emirates....

17 jan 2018
Today, the U.S. Patent & Trademark Office (PTO) issued a final written decision in Argentum Pharmaceuticals LLC's inter partes review (IPR) against the sole unexpired patent listed as covering Janssen Oncology, Inc.'s ZYTIGA® (abiraterone acetate)...

17 jan 2018
WELL is pleased to announce the launch of its WELL Web Platform for both patients and providers, delivering convenient healthcare anytime, anywhere. WELL's simple, easy to navigate telemedicine platform connects patients worldwide to a global...

17 jan 2018
Safa M. Osman, MD is recognized by Continental Who's Who as a Pinnacle Professional Member in the field of Internal Medicine in recognition of her role as an Internist at Valley Health Internal Medicine.                 Dedicated to the health and...

17 jan 2018
GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced that it will proceed with a Phase 2/3 clinical trial for GC1102 (also known as Hepabig-gene), the company's investigational...




News published on 5 october 2017 at 18:57 and distributed by: